We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

CAROLINA LIQUID CHEMISTRIES

Carolina Liquid Chemistries offers a complete line of clinical chemistry analyzers and reagents for use on common pla... read more Featured Products: More products

Download Mobile App




First-of-its-Kind Vitamin-D Assay Provides Results in Minutes

By LabMedica International staff writers
Posted on 12 May 2014
Print article
Image: Vitamin D-Direct – the first direct vitamin D assay – no pretreatment, providing results in 20 minutes, with up to 400 tests/hour, on the CLC720 Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries).
Image: Vitamin D-Direct – the first direct vitamin D assay – no pretreatment, providing results in 20 minutes, with up to 400 tests/hour, on the CLC720 Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries).
Image: The automated CLC720 Chemistry Analyzer provides discrete, efficient, and precise analysis, with multiple features including random access and 12 wavelengths (Photo courtesy of Carolina Liquid Chemistries).
Image: The automated CLC720 Chemistry Analyzer provides discrete, efficient, and precise analysis, with multiple features including random access and 12 wavelengths (Photo courtesy of Carolina Liquid Chemistries).
An innovative assay kit provides the first direct test for Vitamin D, on the CLC720 analyzer, reducing labor and reagents, and providing a high-quality measurement in 20 minutes.

Carolina Liquid Chemistries Corp. (Winston-Salem, NC, USA) now provides "Vitamin D-Direct," the first direct—no pretreatment—Vitamin D test, currently available only on the automated CLC720 general chemistry analyzer. The company takes inefficient complex tests and develops user-friendly applications on clinical chemistry analyzers so that these tests can be performed at, or as close as currently possible to, point-of-care.

With this assay, the CLC720 analyzer can produce a Vitamin D result in 20 minutes without a technologist having to manually pretreat the specimen or the reagent. “The reality of a no-pretreatment Vitamin D-direct assay in minutes exemplifies innovation in clinical chemistry,” said Phil Shugart, president of Carolina Liquid Chemistries. The CLC720 analyzer can run up to 400 Vitamin D tests/hour, and can be run in random access mode with other chemistry tests, eliminating the need for batch testing. In comparison, microtiter plate Vitamin D tests are run in batch and require from 2 to 7 hours to complete.

Testing Vitamin D levels has become the cornerstone for the diagnosis and management of Vitamin D deficiency, which clinical studies have linked to pain, cancer, cardiovascular disease, diabetes, osteoporosis, multiple sclerosis, and Alzheimer’s disease.

Carolina Liquid Chemistries’ Vitamin D-Direct is an innovative homogenous immunoassay which measures the true total 25-Hydroxy Vitamin D. This new, FDA-cleared assay introduces a number of enhancements which include the following: a wide dynamic range with improved precision, elimination of time-consuming washing steps, and the elimination of inaccurate results caused by “matrix effects.” It correlates with LC/MS/MS, and has a 30-day on-board stability. The test is traceable to the newest standard reference material from the National Institute of Standards and Technology (NIST).

Related Links:

Carolina Liquid Chemistries 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.